EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Vancomycin Protects Against Lung Injury and Promotes Butyrate Metabolism

Jianuo Chen iD, Shanshan Su, Xi Zhang, Fen Xiong, Hong Zheng, Wenli Zhang, Yuying Shen, Pengcheng Lin, Hongchang Gao, Yuping Li

The FASEB Journal · 15.07.2026 · 40 (13)

DOI: 10.1096/fj.202504636rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 29.06.2026. Verfasst von Jianuo Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Fifth Affiliated Hospital of Wenzhou Medical University (Lishui Central Hospital), Lishui Hospital of Zhejiang University, Lishui, China. Hauptthemen laut MEDLINE: Vancomycin, Butyrates, Acute Lung Injury, Gastrointestinal Microbiome. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung injury is one of the most common clinical respiratory diseases, caused by the exposure of lung tissue to various stimuli (including hypoxia, ischemia–reperfusion, and foreign substances). Among them, chronic lung injury is characterized by continuous inflammation in the lungs, which damages the endothelial and epithelial cell barriers within the lungs. Clinically, it presents as severe hypoxia and diffuse functional impairment, and on imaging, it shows diffuse alveolar damage, accompanied by varying degrees of inflammation and airway obstruction. Several studies have highlighted the role of gut microbiota in modulating immune responses and pathological features of respiratory diseases through the gut‐lung axis. However, the precise metabolic mechanism remains unknown. A lung injury model was generated by transplanting microbiota from acute lung injury (ALI) patients into healthy C57BL/6J mice. The changes in the gut microbiota and metabolic phenotypes of the feces samples from ALI patients and lung‐injured mice were analyzed using 16S rRNA sequencing technology and metabolomics based on 1 H‐nuclear magnetic resonance ( 1 H‐NMR), respectively. The effect of gut microbiota on lung injury was also explored after giving an oral vancomycin treatment to lung‐injury mice. The data presented here show that Firmicutes formed the vital species of microbiota that was different in lung‐injury mice. Moreover, butyrate (produced by Firmicutes ) was the most crucial metabolite in the feces samples of ALI patients and lung‐injury mice. ELISA and Hematoxylin–Eosin results showed aggravated functional disturbances in the intestinal barrier of ALI patients and lung inflammation in the lung‐injured mice. These phenomena were significantly alleviated after the oral administration of vancomycin. Besides, the utilization of butyrate in the colon of mice was increased considerably. Thus, vancomycin can affect the metabolism of butyrate in the colon by influencing the intestinal microbiota, and it can help in the treatment of lung injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinButyratesAcute Lung InjuryGastrointestinal MicrobiomeLung InjuryAnimalsMiceMice, Inbred C57BLHumansMaleAnti-Bacterial AgentsLung

Stichwörter der Autor:innen

gut microfloralung injurylung‐gut axisnuclear magnetic resonance

Substanzen

VancomycinButyratesAnti-Bacterial Agents

Autor:innen und Institutionen

  • The Fifth Affiliated Hospital of Wenzhou Medical University (Lishui Central Hospital), Lishui Hospital of Zhejiang University, Lishui, China.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health); School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Key Laboratory of Efficacy Evaluation of Traditional Chinese Medicine and Encephalopathy Research of Zhejiang Province, Wenzhou, China.

ORCID-Profile: Jianuo Chen

Förderung

  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Chen, J., Su, S., Zhang, X., Xiong, F., Zheng, H., Zhang, W., Shen, Y., Lin, P., Gao, H., & Li, Y. (2026). Vancomycin Protects Against Lung Injury and Promotes Butyrate Metabolism. The FASEB Journal, 40(13). https://doi.org/10.1096/fj.202504636rr

Vancouver

Chen J, Su S, Zhang X, Xiong F, Zheng H, Zhang W, et al. Vancomycin Protects Against Lung Injury and Promotes Butyrate Metabolism. The FASEB Journal. 2026;40(13). doi:10.1096/fj.202504636rr

BibTeX
@article{Chen2026,
  author = {Chen, Jianuo and Su, Shanshan and Zhang, Xi and Xiong, Fen and Zheng, Hong and Zhang, Wenli and Shen, Yuying and Lin, Pengcheng and Gao, Hongchang and Li, Yuping},
  title = {Vancomycin Protects Against Lung Injury and Promotes Butyrate Metabolism},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {13},
  doi = {10.1096/fj.202504636rr}
}
Kostenlos starten →